PITTSBURGH, Sept. 20, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug ...
back, Matrix was still one of the few domestic pharma companies amongst MNCs, the status has now changed with the US-based generic pharma company, Mylan Laboratories, acquiring up to 71.5% stake in ...
With new life-saving drugs being created every day, the pharmaceutical industry is directly involved in saving human lives across the world. With how important the work of this sector is, it becomes ...
Kotak Alternate Asset Managers Limited (Kotak Alt), announced an investment of Rs. 1,445 crore for acquisition of API business of Viatris by Matrix Pharma Private Limited (Matrix). The acquisition has ...
Srini Sriniwasan, Managing Director, Kotak Alternate Asset Managers Limited, said, “This buy-out of a significant business along with key incumbent management coming on board, demonstrates Kotak Alt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback